TRIP13 participated in several cancer-related pathways and the oncogenic potential in tumorigenesis may be likely involved in epigenetic regulation, miRNA-target interaction and the degree of aneuploidy, as well as the immune mediation in the tumor microenvironment. This evidence concerns the gene TRIP13 and neoplasm.